Invesco’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.44M | Buy |
301,002
+205,958
| +217% | +$1.51M | ﹤0.01% | 2495 |
|
|
2026
Q1 | $607K | Sell |
95,044
-13,257
| -12% | -$85.5K | ﹤0.01% | 3081 |
|
|
2025
Q4 | $644K | Buy |
108,301
+44,484
| +70% | +$236K | ﹤0.01% | 3104 |
|
|
2025
Q3 | $339K | Buy |
63,817
+13,835
| +28% | +$58.7K | ﹤0.01% | 3374 |
|
|
2025
Q2 | $171K | Buy |
49,982
+12,351
| +33% | +$39.4K | ﹤0.01% | 3556 |
|
|
2025
Q1 | $111K | Buy |
37,631
+17,707
| +89% | +$55.4K | ﹤0.01% | 3613 |
|
|
2024
Q4 | $60.8K | Buy |
19,924
+1,182
| +6% | +$3.44K | ﹤0.01% | 3676 |
|
|
2024
Q3 | $47.8K | Sell |
18,742
-100,090
| -84% | -$303K | ﹤0.01% | 3693 |
|
|
2024
Q2 | $387K | Buy |
+118,832
| New | +$522K | ﹤0.01% | 3386 |
|
|
2022
Q2 | – | Sell |
-11,855
| Closed | -$34K | – | 4116 |
|
|
2022
Q1 | $34K | Buy |
11,855
+35
| +0.3% | +$91 | ﹤0.01% | 3956 |
|
|
2021
Q4 | $36K | Sell |
11,820
-3,550
| -23% | -$15.4K | ﹤0.01% | 4002 |
|
|
2021
Q3 | $108K | Buy |
15,370
+2,545
| +20% | +$19.1K | ﹤0.01% | 3925 |
|
|
2021
Q2 | $118K | Buy |
12,825
+1,980
| +18% | +$20.1K | ﹤0.01% | 3874 |
|
|
2021
Q1 | $106K | Buy |
+10,845
| New | +$121K | ﹤0.01% | 3755 |
|
|
2018
Q1 | – | Sell |
-129,447
| Closed | -$12.8M | – | 3758 |
|
|
2017
Q4 | $12.8M | Buy |
129,447
+59,568
| +85% | +$6.67M | ﹤0.01% | 1443 |
|
|
2017
Q3 | $8.37M | Buy |
+69,879
| New | +$6.5M | ﹤0.01% | 1670 |
|
|
2017
Q1 | – | Sell |
-51,803
| Closed | -$1.59M | – | 3739 |
|
|
2016
Q4 | $1.59M | Buy |
+51,803
| New | +$2.24M | ﹤0.01% | 2738 |
|
|
2016
Q1 | – | Sell |
-3,962
| Closed | -$311K | – | 3744 |
|
|
2015
Q4 | $311K | Sell |
3,962
-1,497
| -27% | -$118K | ﹤0.01% | 3432 |
|
|
2015
Q3 | $411K | Sell |
5,459
-37,662
| -87% | -$3.56M | ﹤0.01% | 3330 |
|
|
2015
Q2 | $5.03M | Sell |
43,121
-66,789
| -61% | -$12.1M | ﹤0.01% | 1983 |
|
|
2015
Q1 | $26M | Buy |
109,910
+49,132
| +81% | +$10.5M | 0.01% | 1090 |
|
|
2014
Q4 | $11.5M | Buy |
60,778
+32,803
| +117% | +$7.28M | ﹤0.01% | 1474 |
|
|
2014
Q3 | $6.67M | Buy |
+27,975
| New | +$5.74M | ﹤0.01% | 1747 |
|
|
2014
Q1 | – | Sell |
-44,589
| Closed | -$4.62M | – | 4222 |
|
|
2013
Q4 | $4.62M | Buy |
44,589
+12,452
| +39% | +$731K | ﹤0.01% | 2064 |
|
|
2013
Q3 | $1.72M | Buy |
+32,137
| New | +$1.73M | ﹤0.01% | 2649 |
|
Other funds holding PBYI
ACA
Invesco's PBYI Position: Q2 2026 in Review
Invesco increased its Puma Biotechnology (PBYI) stake by 217% in Q2 2026, buying an estimated $1.51M and bringing the position to 301,002 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2495.
Invesco first reported a position in PBYI in Q3 2013 and has held it in 25 quarters since. The position peaked at $26M in Q1 2015. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- Invesco held 301,002 shares of Puma Biotechnology worth $2.44M as of Q2 2026.
- Invesco bought 205,958 Puma Biotechnology shares in Q2 2026, an estimated $1.51M.
- Puma Biotechnology made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2495 holding.
- Invesco first reported a position in Puma Biotechnology in Q3 2013 and has held it in 25 quarters since.
- Invesco's Puma Biotechnology position peaked at $26M in Q1 2015.
- 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.